Articles
-
Sep 20, 2024 |
cellandgene.com | Laura Keita |Philip Ross |Antony Hitchcock |AGH Bioconsulting
Tessera Therapeutics' CEO, Dr. Michael Severino, joins Host Erin Harris to discuss Gene Writing, the biotech's genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Severino discusses why delivery has always been a challenge for gene editing technologies and why Gene Writing is different when it comes to efficient delivery. Better Audits, Faster Through Transparency And EfficiencyClinical trial audits are evolving.
-
Dec 9, 2023 |
codeproject.com | Philip Ross
A mouse wearing virtual-reality goggles? Now I’ve seen everything. The point is to show everything to a mouse. Brain researchers would love to do that by setting a mouse free in a little playground while probing its brain. But the probes involve lasers, microscopes, and other apparatus far too heavy for such a small head. Each mouse eye covers 140 degrees, as much as both human eyes put together—the better to detect a swooping hawk.
-
Sep 2, 2023 |
spectrum.ieee.org | Philip Ross
Early chess computers were better than grandmasters at calculation but worse in judgement, and so the idea arose to pair them to get the best of both worlds. It worked, but not for long: Computers finally got too good to need human advice. Are we now at that sweet spot in aerial warfare where human-machine collaborations still make sense? That’s the “loyal wingman” concept, where a human pilot supervises a flock of relatively inexpensive but AI-guided drones.
-
Sep 2, 2023 |
flipboard.com | Philip Ross
Military12 hours agoRussia's Vast Fortifications in Ukraine, VisualizedThe Wall Street Journal. - Anastasiia Malenko, Juanje Gómez, Jemal R. Brinson, Emma Brown • 12hWhen Ukrainian forces launched a counteroffensive in early June, they soon became bogged down in an elaborate defense network of obstacles that Russia spent months building.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →